<SEC-DOCUMENT>0001104659-17-022965.txt : 20170412
<SEC-HEADER>0001104659-17-022965.hdr.sgml : 20170412
<ACCEPTANCE-DATETIME>20170412070042
ACCESSION NUMBER:		0001104659-17-022965
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20170412
DATE AS OF CHANGE:		20170412
EFFECTIVENESS DATE:		20170412

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Innoviva, Inc.
		CENTRAL INDEX KEY:			0001080014
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				943265960
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30319
		FILM NUMBER:		17756992

	BUSINESS ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 500
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		6502389600

	MAIL ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 500
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	THERAVANCE INC
		DATE OF NAME CHANGE:	20020207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED MEDICINE INC
		DATE OF NAME CHANGE:	20000302
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>a17-2335_23defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>


<html>
<head>






  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;font-weight:bold;">UNITED STATES<br>  </font></b><b><font size="4" style="font-size:14.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;font-weight:bold;">SCHEDULE 14A</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Proxy Statement Pursuant to Section 14(a) of<br> the Securities Exchange Act of 1934 (Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filed by the Registrant&nbsp;&nbsp;</font><font face="Wingdings">x</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filed by a Party other than the Registrant</font>&nbsp;&nbsp;<font face="Wingdings">o</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box:</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preliminary Proxy Statement</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Confidential, for   Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitive Proxy Statement</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Definitive Additional Materials</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Soliciting Material under &#167;240.14a-12</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;font-weight:bold;">INNOVIVA, INC.</font></b></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name   of Registrant as Specified In Its Charter)</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name   of Person(s) Filing Proxy Statement, if other than the Registrant)</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Payment of Filing Fee (Check the   appropriate box):</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No fee required.</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fee computed on table below per   Exchange Act Rules 14a-6(i)(1) and 0-11.</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font></p>    </td>
<td width="90%" valign="top" style="padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title of each class of securities to   which transaction applies:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>    </td>
<td width="90%" valign="top" style="padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Aggregate number of securities to   which transaction applies:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>    </td>
<td width="90%" valign="top" style="padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Per unit price or other underlying   value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth   the amount on which the filing fee is calculated and state how it was   determined):</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>    </td>
<td width="90%" valign="top" style="padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proposed maximum aggregate value of   transaction:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5)</font></p>    </td>
<td width="90%" valign="top" style="padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total fee paid:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:4.66%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.3%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fee paid previously with preliminary   materials.</font></p>    </td>   </tr>
<tr style="page-break-inside:avoid;">
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font></p>    </td>
<td width="94%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:94.96%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check box if any part of the fee is   offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing   for which the offsetting fee was paid previously. Identify the previous   filing by registration statement number, or the Form or Schedule and the date   of its filing.</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amount Previously Paid:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form, Schedule or Registration   Statement No.:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3)</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filing Party:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4)</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date Filed:</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in .7pt 0in .7pt;width:5.04%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.36%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="90%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:90.6%;">
<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="36" style="border:none;"></td>
<td width="31" style="border:none;"></td>
<td width="2" style="border:none;"></td>
<td width="639" style="border:none;"></td>   </tr> </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109206\17-2335-23\task8375602\2335-23-ba.htm',USER='109206',CD='Apr 12 07:13 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt 9.0pt;text-indent:-9.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 9.0pt;text-indent:-9.0pt;"><font size="2" face="Times New Roman"><img width="176" height="57" src="g233523bci001.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">April&nbsp;12, 2017</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dear Fellow Innoviva Shareholder:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">THE STAKES ARE HIGH&#151;AND WE THINK THE CHOICE IS CLEAR:</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PLEASE VOTE THE WHITE PROXY CARD TODAY!</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Annual Stockholders Meeting of Innoviva,&nbsp;Inc. is just days away. </font>&#160;We urge you to protect your investment by using the enclosed WHITE proxy card to vote FOR your Board of Directors&#146; nominees. <b>&#160;Since time is short, please vote TODAY by telephone or by Internet, to ensure that your shares are timely represented.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">YOUR HIGHLY QUALIFIED AND INDEPENDENT BOARD HAS A STRATEGY THAT IS PRODUCING RESULTS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Innoviva has delivered a 32% compounded growth rate in royalties over the last 10 reported quarters through an efficient, low-cost structure. With strong and consistent growth in profits, we have been able to deliver increasing returns to shareholders &#151; including capital returns of more than $210 million to investors since the first quarter of 2015.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Strong Growth in Quarterly Profits</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="527" height="173" src="g233523bci002.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SARISSA PROPOSES TO SEVERELY ALTER INNOVIVA&#146;S SUCCESSFUL STRATEGY</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sarissa Capital, under the leadership of Alexander Denner, has advocated that its nominees carry out high-risk cost-cutting once elected, which we believe would greatly impact the ability of your Company to continue its current growth trajectory.&#160; We think shareholders should be alarmed by that fact that <b>during Mr.&nbsp;Denner&#146;s 52-month tenure as Enzon Pharmaceuticals&#146; board chair</b>, which includes Sarissa Capital nominee Dr.&nbsp;Kostas&#146; tenure as a director, <b>Enzon Pharmaceuticals reduced G&amp;A expenses to ~$9 million, and revenues dropped 81%</b>.&#160; Enzon shareholders also suffered a 82.9% decline in stock price and a 51.7% drop in Total Shareholder Return.<b>&#160; Please don&#146;t expose Innoviva shareholders to a similar value destruction.</b></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We urge all shareholders to protect the value of their investment by voting the <b>WHITE</b> proxy card<b> TODAY.</b></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Thank you for your support,</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Directors of Innoviva,&nbsp;Inc</font>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109206\17-2335-23\task8375691\2335-23-bc.htm',USER='109206',CD='Apr 12 07:56 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">TIME IS SHORT&#151;PLEASE VOTE BY TELEPHONE OR BY INTERNET TODAY!</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you have questions about how to vote your shares, please contact:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">INNISFREE M&amp;A INCORPORATED</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(888) 750-5834 (TOLL-FREE from the U.S. and Canada)</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">or (412) 232-3651 (from other locations)</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Banks and Brokers May&nbsp;Call Collect: (212) 750-5833</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Forward-Looking Statements</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This letter contains certain &#147;forward-looking&#148; statements as that term is defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, statements relating to goals, plans, objectives and future events. Innoviva intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section&nbsp;21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. The words &#147;anticipate&#148;, &#147;expect&#148;, &#147;goal&#148;, &#147;intend&#148;, &#147;objective&#148;, &#147;opportunity&#148;, &#147;plan&#148;, &#147;potential&#148;, &#147;target&#148; and similar expressions are intended to identify such forward-looking statements. Such forward-looking statements involve substantial risks, uncertainties and assumptions. These statements are based on the current estimates and assumptions of the management of Innoviva as of the date of this letter and are subject to risks, uncertainties, changes in circumstances, assumptions and other factors that may cause the actual results of Innoviva to be materially different from those reflected in the forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, among others, risks related to: lower than expected future royalty revenue from respiratory products partnered with GSK, the commercialization of RELVAR&#174;/BREO&#174; ELLIPTA&#174; and ANORO&#174; ELLIPTA&#174; in the jurisdictions in which these products have been approved; the strategies, plans and objectives of Innoviva (including Innoviva&#146;s growth strategy and corporate development initiatives beyond the existing respiratory portfolio); the timing, manner, amount and planned growth of anticipated potential capital returns to shareholders (including, without limitation, statements regarding Innoviva&#146;s expectations of future purchases under its capital return programs and future cash dividends); the status and timing of clinical studies, data analysis and communication of results; the potential benefits and mechanisms of action of product candidates; expectations for product candidates through development and commercialization; the timing of regulatory approval of product candidates; and projections of revenue, expenses and other financial items. Other risks affecting Innoviva are described under the headings &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; contained in Innoviva&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016, which is on file with the Securities and Exchange Commission (&#147;SEC&#148;) and available on the SEC&#146;s website at www.sec.gov. Additional factors may be described in those sections of Innoviva&#146;s Quarterly Report on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2017, to be filed with the SEC in the second quarter of 2017. In addition to the risks described above and in Innoviva&#146;s other filings with the SEC, other unknown or unpredictable factors also could affect Innoviva&#146;s results. Past performance is not necessarily indicative of future results. No forward-looking statements can be guaranteed and actual results may differ materially from such statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. The information in this letter is provided only as of the date hereof, and Innoviva assumes no obligation to update its forward-looking statements on account of new information, future events or otherwise, except as required by law.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Reconciliation of Non-GAAP Financial Measures to GAAP<br><br></font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In certain circumstances, results have been presented that are not generally accepted accounting principles measures (&#147;Non-GAAP&#148;) and should be viewed in addition to, and not as a substitute for,&nbsp;Innoviva&#146;s reported results. Innoviva believes that the non-GAAP financial information provided in this letter can assist investors in understanding and assessing Innoviva&#146;s on-going operations and prospects for the future and provides an additional tool for investors to use in comparing Innoviva&#146;s financial results with other companies in Innoviva&#146;s industry or with similar operating profiles. Investors are encouraged to review the reconciliation of Innoviva&#146;s non-GAAP financial measures to their most directly comparable GAAP financial measures.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please see the reconciliation that follows for additional information and the reconciliations of these non-GAAP financial measures to the closest GAAP financial measures.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Reconciliation of GAAP to Non-GAAP Operating Results</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(in thousands)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="73%" style="border-collapse:collapse;margin-left:1.0in;">
<tr>
<td width="55%" valign="bottom" style="padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:20.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Eight&nbsp;Quarters&nbsp;Ended<br>   Dec.&nbsp;31,&nbsp;2016</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:16.36%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Twelve&nbsp;Months<br>   Ended<br>   Dec.&nbsp;31,&nbsp;2016</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.36%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="55%" valign="bottom" style="padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:20.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(unaudited)</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.36%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(unaudited)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.36%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EBITDA:</font></b></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.36%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">GAAP net income</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.54%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="18%" valign="bottom" style="padding:0in 0in 0in 0in;width:18.46%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">40,776</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.54%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="14%" valign="bottom" style="padding:0in 0in 0in 0in;width:14.82%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">59,536</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Non-GAAP   adjustments:</font></b></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.36%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Interest expense   (income), net</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">103,294</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:16.36%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51,834</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock-based   compensation</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15,171</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.36%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8,297</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Depreciation</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">240</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:16.36%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">131</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="16%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.36%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amortization of   capitalized fees paid to a related party</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:20.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27,646</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.36%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13,823</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.48%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">*Adjusted   EBITDA</font></b></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.54%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="18%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:18.46%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">187,127</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.54%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="14%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:14.8%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">133,621</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.36%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109206\17-2335-23\task8375691\2335-23-bc.htm',USER='109206',CD='Apr 12 07:56 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g233523bci001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g233523bci001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  Y + # 2(  A$! Q$!_\0
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E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g233523bci002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g233523bci002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" "M @\# 2(  A$! Q$!_\0
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M&>">: .WU/P7;ZGJBWKW4J,-2M]0VA1C="FT+]#698?#"SL)[65+^X8VWV;
M*KSY+[Q^?2J_@2_O;+2=7LM3GO)-5LSEDO+T7)W%"P53@=,'(&>E,\*M>6NM
M:%*VNWNH#6;"2YN8+B7>L3X0Y0?P#)(Q[$?0 F'PJMX]*T^RMM9U"V-I&\$D
ML!"-/$TC.4;';+'CD5J2> K)_-59Y4BDNK6X"* -H@14501V(0<UU-1RR^5C
M]V[Y_NC.* .;\)>!;7PE<WD\-Y<W<MTW+W!!8+V!/?I7457^U_\ 3"?_ +XH
M^U_],)_^^* +%%5_M?\ TPG_ .^*/M?_ $PG_P"^* +%%5_M?_3"?_OBC[7_
M -,)_P#OB@"Q15?[7_TPG_[XH^U_],)_^^* +%%5_M?_ $PG_P"^*/M?_3"?
M_OB@"Q15?[7_ -,)_P#OBC[7_P!,)_\ OB@"Q15?[7_TPG_[XH^U_P#3"?\
M[XH L457^U_],)_^^*/M?_3"?_OB@"Q15?[7_P!,)_\ OBC[7_TPG_[XH L4
M57^U_P#3"?\ [XH^U_\ 3"?_ +XH L457^U_],)_^^*/M?\ TPG_ .^* +%%
M5_M?_3"?_OBC[7_TPG_[XH L457^U_\ 3"?_ +XH^U_],)_^^* +%%5_M?\
MTPG_ .^*/M?_ $PG_P"^* +%%5_M?_3"?_OBC[7_ -,)_P#OB@"Q15?[7_TP
MG_[XH^U_],)_^^* +%%5_M?_ $PG_P"^*/M?_3"?_OB@"Q15?[7_ -,)_P#O
MBC[7_P!,)_\ OB@"Q15?[7_TPG_[XH^U_P#3"?\ [XH L457^U_],)_^^*/M
M?_3"?_OB@"Q15?[7_P!,)_\ OBC[7_TPG_[XH L457^U_P#3"?\ [XH^U_\
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MX_D*9%H=W>NLFI7#,.I0G./IV% 'C/BA2OBC5&(X>ZDD4^JEB01^!K*K3\2
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MEZGMO]IZKJ1Q9P^1'G!;&3^9XJ>V\-1!_-O)6FD)R??ZYZUMJH10J@!1T '
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MK%% %?[#;_\ //\ \>-'V&W_ .>?_CQJQ10!7^PV_P#SS_\ 'C1]AM_^>?\
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M7]3M$#2Q>4K'"EDSFLR3Q/?R?\O##_=4"NHU32)-7CC2X=%"'(V''\P:S?\
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M$8_NUR1CCKJ[_+_(Z>;"+9?F>'T5ZU_PJ+3O^?N[_P"_B_\ Q%'_  J+3O\
MG[N_^_B__$5Z9?UFF9_PA$CIJPA94(,19CSG[^!_/\Z](\J[_P"?A?\ OD5B
M>&?"*>%?M/V&5I/M.W?YS9QMSC& /[QK=_TO_IA^M!PUI*4VT>:W.?M4V>3O
M.?SJ*NQD\'QR2,[2MEB2<-_]:F_\(7%_SV?_ +Z'_P 37@/+ZS?0]-8RE8\V
M\4_\@R/_ *[#^1KE*]JO_AY;:C L4UQ,JJV[*. <X(_N^]9__"HM._Y^[O\
M[^+_ /$5ZN$I2I4^66Y$L53;/):]F^&BS/X.A\IUC ED!XSDYZ_Y]*I_\*BT
M[_G[N_\ OXO_ ,174:!H3>'=,6QLW#Q!B^93ELGZ 5U'-7K1G&R&>(X[A="N
M3),&7Y<C;_M"N%KT>_LI]1LY+:8QJCXR4)SP0?Z5C_\ "%Q?\]G_ .^A_P#$
MUY>-PE2M44H=C3"XB%*#4NYR%<IXI_Y"<?\ UQ'\S7K7_"%Q?\]G_P"^A_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG_/*7_OFC[<G_/*7_OFK5% %7[<G_/*7_OFC[<G_ #RE_P"^:M44 5?MR?\
M/*7_ +YH^W)_SRE_[YJU10!5^W)_SRE_[YH^W)_SRE_[YJU10!5^W)_SRE_[
MYH^W)_SRE_[YJU10!5^W)_SRE_[YH^W)_P \I?\ OFK5% %7[<G_ #RE_P"^
M:/MR?\\I?^^:M44 5?MR?\\I?^^:/MR?\\I?^^:M44 5?MR?\\I?^^:/MR?\
M\I?^^:M44 5?MR?\\I?^^:/MR?\ /*7_ +YJU10!5^W)_P \I?\ OFC[<G_/
M*7_OFK5% %7[<G_/*7_OFC[<G_/*7_OFK5% %7[<G_/*7_OFC[<G_/*7_OFK
M5% %7[<G_/*7_OFC[<G_ #RE_P"^:M44 5?MR?\ /*7_ +YH^W)_SRE_[YJU
M10!5^W)_SRE_[YH^W)_SRE_[YJU10!5^W)_SRE_[YH^W)_SRE_[YJU10!5^W
M)_SRE_[YH^W)_P \I?\ OFK5% %7[<G_ #RE_P"^:/MR?\\I?^^:M44 5?MR
M?\\I?^^:/MR?\\I?^^:M44 5?MR?\\I?^^:/MR?\\I?^^:M44 5?MR?\\I?^
M^:/MR?\ /*7_ +YJU10!5^W)_P \I?\ OFC[<G_/*7_OFK5% %7[<G_/*7_O
MFC[<G_/*7_OFK5% %7[<G_/*7_OFC[<G_/*7_OFK5% %7[<G_/*7_OFI(;A9
MB0%=<?WABIJ* "O+/%OB5_''AECX:%_/ID4WE:G';0@3E3@J4!Y(R#D#\< &
MO4ZYOQ?X3'BC^S"LY@>TN=[NK$,8B"'4$=">,'VH Y+4+S4-9T^#^S_$-[:0
MV&B_VBLP&QYVW.N)1GD )Z]23S72ZC=:GJ?PU@U"WO#9W;V"7<\B+@G]WO95
M_NY/&>U3WGP_T&^6P62U=%L4$<8CE90R;MVUL?>!(S3[OP/I%WI=QIQ%Q%;3
MW'VAUAF*?-L"8X_AV@<4 8GB./4M9U2.RM=;N],2RTM;\/;M@RR%F&'_ +RC
M:.,]S^'6>'[R;4?#FF7MSCS[FTBEDP,#<R GCZFL>[^'>AWL-HDXNV-K'Y2N
M+A@SIQE6/\0X[UTT,,=O!'#"@2*-0B*.B@# % #Z*** "BBB@ HHHH XG4X=
M8U[Q)JT-GX@ETF#2EC")&BD.S)OWOD=.WX'ISE]IJ6K7T/A74GO0EO>;(YX$
M08E<H[;R?3Y1@#UJUXE^'ND^*-06]N9KVVG\LQ2-:RA1,G8.""#CGTZ\YXQG
MK\+X)6L7OM=U>9[# @V3!5V@Y4$$,2>2,Y''I0!9^(9O;72&OX/$4FDP01MB
M**%6>XF(^10QYZ\8 ]3VXR-5NO$5XE](FLRZ9/H^E0W3QI$A$TC(S/O!_P!S
M'' ]*W_%7@#3?%S6#7UU?P/8@B)[:55)SCDY4\C:.1BLB^\)>$]1ET^2YU.Z
M9[(!6/G_ /'RH?>%E^7D YZ8//7@8F4XQ^)V*492V1/IE]K4OB?48KB],RSZ
M0EY;0(@5869G  ]3\O4^M5/AM?ZZVHWEEXE-^EWY*S1QW3JPV;B,C &.?K4B
M>$_"ZZ_<ZJ^L7LC7(=)+=IQY.QLY0 *"%&3@9XJ]X2T/P[X7E9=/U":ZN)PL
M0DN9 [[0>$& ,#)J?;4_YE]X_9S[,ZRYE^SVTLP7<8T+;<]<#.*\TT_4/$ T
M33/%4_B02"_GB1M/:-!$0[A=B=]P )]>#R<'/82^--'CEU:&25O,TM"]RA7D
MJ,9*CJ1R!GWK$O?A+I,E\]YIU]J%A-YHFA2*7,4+]RHQN&>I^;].*T($\.SZ
MC!X[FTYO$<NM)';N]\IA5([>3<-JC'0]?ESV_)-:N-1L?'NF0V_B*:::[NE/
M]E)"NR.U .]F//H>3C.>!Q3?#'A#0/#,4OBG3M3U.XM_(DF<2./+<8)9MFT'
M/!QFK,7@31M<UZ'Q?;7NIQ37B17"HDJJC+M7 (VYP0 2,]: ,;P_JGB/4'T;
M4CK18ZW)<1O:O$ICM]BN5*\ C[@ZYSGDGOH:A+XC;P%.NGW%W>ZK#?O"TL)5
M)'59"I(XP.!Z5H1_#+0X+F_FMGO(#>(R*J3<6VX?,T602I/?K[8'%1P?##2H
M=!N-*_M#5G2:=;A9WN!YL3C/*$+@9!(.0>IH N^ -3EU3PPDEQ+<2W,4KPS&
M<@LKKPPR ,X/M5SQ?J5QI/AB\N[-UCG78B.V,(7=4W<@CC=GD=JM:'H=CX=T
MQ+'38O+A4ECDY+,>K'W/Y>F!4^H6%MJEA/97L0EMIT*2(21N!]QR/PH X62+
MQ%X?U.+21XDFU"34+*=UDDMU:2"2-00ZKGD'. ">M2_#'5M6O9M6M=9EO2\+
M1O#%?+MF12#DG@=2!QV_G'%\'["UDB%KK&J^04,-Q%+*&\Z'!_=Y7;@ G(ZX
M]*Z3POX/L/"<5PMG+=7,MPX>2>Z</(<  #( X&/\\4 <>=7UK1+OQ(L>O/K'
MV*P\R21H%6.WN2YPH SC"Y..>G/3%.U3_A)-&MM<L(O$LUQY&F#48[B6%?,0
M#S,H".NXJ.>PZ>^SH_PNT719KHQ7&HSP72NLMM/.#&0P(/10<X/7.>!S42?"
M?1DT.?3!>ZIMN)A+)<>>OG, NT(6VXV8[8H RO&M]XFBM]&N]*.H-9BR$MY)
M;2*N" "2V0>V:]%L)EN=/MID9F62)7#-U((!R:Y*?X5Z-<PV,<UWJ;?9(C#N
M,XS-&3G8_P O('.,8Z_3'911)!"D42A(XU"JHZ #@"@#F_%DFH76IZ3HVGZB
M^F_;C*\EQ&H+XC"G:N?7=^GX'EM1\5:EH5C=Z)-K=O->B\^SQ:A<,D96+RU=
MB3TWKO ^IKJO'&G:%J>F0PZ_=O9 2;K>XBDV2(XZ[3@CD<'(/7UP:YC2=-\$
M::]PD^L6^HVTA+Q1WJ+*T#G[SJ2, G Z =!G-!2C)[(Z&UNI]9^&NGW<>NK8
MN]G%)<Z@ KE<*/-Y)P#D,">QSQ7+:;JVN:K;Z/I<.N72VVHWEX(M2,2K-)!$
M%*'D=R6]#T'3@Z]Z?!5[X,3PP=72*P1$0-"P60[2&W'Y<$DC)..22>M0VW@G
MPI>>#Y(H=5OKBSL7:5+W[0/,MBJ@L%.T #;C@@\>^* <9+=%G2+_ %NXM_#M
MW=:GOB>ZELYT6(+Y[*TH$A/;B->!ZFJ+7_B&R^)8&H'48]&GNQ#;MYB^2^5^
M4;=N>H/>KUKX-T'Q38Z-JFG7NJ6UI:QA;>*&01J=KMDLI4G<26!JKH6G>%KO
MQ7::C =1-Y=O-<06]P08HWB8QNX S@E@6Z]^W0!)Z+7$:G#K.O>)=5AL_$,F
MDVVE)&%2.-2'9D#[W)_A'3'/3MSGMZXWQ#X*T#Q=X@E::YO+?4;>W5;@6K[/
M,B?.T/N4@CY&Z?CVH J6NLZSJ-AX5U5[T10W<R03P1H,2L2_SD^F$' XY/M6
MA\1)+JUT$WL&O2:2ENKG;%&&>YD(_=H">1SG@#G/;%9R_"FWGCM!J.OZS.]F
M<0%)@@50Q*@@AN1G&01QV%+XDL=!\8^$+;6+^;5+:TTUY&1X"HERCF,G&&!Y
M3(QS]* ,^ZN_$NH6EY-+K%QIEQI&EQW31+"@\YV5V.]2./N 8'3GBMNSU'5[
M74[R\O+L74;Z6;R&S"B-(R#D#< 3ST)(./?H.+NKWP#=Z9IFISWNM-%9,+4O
M_%=!3O"RC'S#KR,'GZ8U&_X1+1KV'Q<^IZP\5\LLJ0-@Q!0ZJZ;-H( 9P,9[
M4 6OAEXDU'6M2N?[8N-1,]Q;BXBBGA5(=N[!,>.<#<HSWY]Z](KRCPUXI\#>
M&([S4-/?5"DCA0)HBWE(V6")P#L&T]<X]>37;6GCK0[WPY<:W;W3/9VX'F_(
M0ZD]%QW)) H Y6UNM>_LJR\5OXA<I=74:G3F1/*V/($\M3C.X>O7@]>M:'AZ
M35+;QU)ITWB.36E2W>2]7R52.W<M\@&"=IZ_+GMGZ01_#G1-<1=;T74=2LOM
M3+>0*DG[N%SSD*1N!R3D;NI(X'%:7AGX;:;X6U=M1L[_ %*25PV^.653&Q;J
M=H4?AS0!4UJ74K'QUIB6_B.6:6[NU_XE21+MCM@IWLW4]C\QQG/'2L;3-<\1
MW3Z)JXU8XUNYFMVL6B4Q6^-P4CC(QM!/KW/KTUU\-]+NO%S^(OMNI17DC*S)
M%,HC. !C&W.#M'&:?'\.=$AU*_O8OM*/>*ZJBR#9;EQAFB&/E)Z]P#T P* ,
M/6M=UO2? FV*ZGNM1DU-[ W$48,I 9QE$Q@L=N /?CG%;_P^U&74?#9-U-?2
M74,[Q3"^0+*C#!VD#V(_/%5;;X8:3;Z)<Z6U[JD\4\@E$DLZF2)P00R$*,'(
M]#U-=!H.AVOAW2TL;,R,@)9I)6R\C'JS$ #)QSQ0!3\;:O<Z%X/U#4+$9N8D
M41\ X+,%S@@],YZ5RLO_  D>B:S:Z8OB:2_.J6-Q*':W1FAD100R*,9!SP.G
M!KT"_L+;5+":RO8A+;SJ4D0DC<#[CFN''P@TN&=&MM3U-8B#%+%)-N#PD']V
M",$ 9XSG&!0!)\--5U2\DU.UUB34-\7EO#%J";9PI!#$C P"1P/Q[\X\VLZ]
MH>IZZEOKTFL+9V)DN)&MU6*WG).%&,X(&#MY[YZ<=OX7\(V/A2&=+6>[N99W
MW//=R!Y" ,!<@#@?UK(TKX6Z+I-Y=31W.HS0W2R)+:S3@Q,'&#P%!SCH<YH
MSY(/$6GSZGI,7B6>;%@MZMU+"C21#+J57C!SM!Y].,=:I>-O%.LVHT6QL&O5
M6:Q%W<362AYGX Y!&%4=2W\L<V]8\">'/#7@ZZ6^U+5TM_.222Y696N&XV+&
M#MY7GIC^56+_ ,'>'F\$V=Y-<:E/::9;M>1SK(OG2P[-QC;(P5( ^4@?4<T
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..%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
